Program Description
Demodex blepharitis is a common inflammatory ocular condition caused by mite overgrowth affecting the eyelids, eyelashes, lash follicles and sebaceous glands. Despite its high prevalence, there is a lack of routine screening, standardized diagnostic criteria, and disease awareness among health care providers, including pharmacists. Misdiagnosis and underdiagnosis occur frequently and are concerning, as untreated cases can lead to ocular discomfort, complications, and adverse effects. Pharmacists and pharmacy technicians play a crucial role in recognition and clinical management of Demodex blepharitis, acting as patient identifiers, advocates, and educators. This program will review the pathophysiology of Demodex blepharitis, treatment and adherence recommendations, and education strategies to improve patient outcomes. Participants will explore traditional therapies and gain insights into the first FDA-approved treatment, including its efficacy, safety, and practical applications.
Target audience: Community Pharmacist, Managed Care Pharmacist, Retail Pharmacist, Specialty Pharmacist
Type of activity: Application
Release date: June 19, 2025
Expiration date: June 19, 2026
Time to complete activity: 1.5 hours
Learner level: Introductory
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the clinical signs and symptoms of Demodex blepharitis and the impact on patient quality of life
- Explain the role of newly approved targeted therapy in addressing the limitations of treatment options for Demodex blepharitis, including short-term efficacy and potential adverse effects
- Provide patient counseling on the proper administration and dosage of Demodex blepharitis medications, including eyelid hygiene techniques
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here